Scholar Rock is a clinical-stage biopharmaceutical company.
51 - 200
π° $205M Post-IPO Equity on 2022-06
6 days ago
51 - 200
Director of National Accounts for Scholar Rock's SMA drug launch.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β° Full Time
π΄ Lead
π¬ Director
6 days ago
51 - 200
Director of National Accounts for SMA drug launching at Scholar Rock.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β° Full Time
π΄ Lead
π¬ Director
October 1
51 - 200
Director of Clinical Quality Assurance at Scholar Rock with expertise in GCP Compliance.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β° Full Time
π΄ Lead
π§ QA Engineer (Quality Assurance)